Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- S-P to Increase Its MRs to 600 to Detail Ribavirin
December 31, 2001
- GSK's Flutide Diskus Included in NHI Price List
December 31, 2001
- The Year 2001 in Retrospect:
December 31, 2001
- BUSINESS NEWS IN BRIEF
December 31, 2001
- Innovation and Reward - Contributing to a Healthy and Growing Economy
December 31, 2001
- Takara Shuzo Develops New Gene Transfer Technology, rPIC Method
December 31, 2001
- Perspective for 2002
December 31, 2001
- J&J: New Breast Cancer Biopsy System
December 31, 2001
- Disasters That Never Come
December 31, 2001
- Sugi Pharmacy to Maintain 30% Growth Rates
December 31, 2001
- Aiming to Enter Top 10 Next Year: Mr Dunoyer of GSK
December 31, 2001
- Fujisawa Licenses Tacrolimus-coated Stents to JOMED of Netherlands
December 31, 2001
- New Year's Greeting
December 31, 2001
- Appropriate Use of Insulin Explained: Novo Nordisk Seminar
December 31, 2001
- What Price Do Patients Pay?
December 31, 2001
- Chuikyo Approves Inclusion of Zithromac in NHI Price List
December 31, 2001
- Imigran Tablets Selling Better than Expected: GSK
December 24, 2001
- Health Minister Concerned About Higher Price of Reagent for Blood Test
December 24, 2001
- BUSINESS NEWS IN BRIEF
December 24, 2001
- Sanko Junyaku: Microplate EIA System
December 24, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…